DEFERRED ROYALTY OBLIGATION RELATED TO THE SALE OF FUTURE ROYALTIES - Schedule (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Non-cash interest expense related to the sale of future royalties	$ (2,219)	$ (1,576)	$ (4,290)	$ (3,278)
Deferred Royalty Obligation [Roll Forward]
Deferred royalty obligation balance as of January 1,			25,527
Deferred royalty obligation balance as of June 30,	27,761		27,761
Healthcare royalty partners IV, L.P
Deferred Royalty Obligation [Roll Forward]
Deferred royalty obligation balance as of January 1,			25,527	20,179
Non-cash interest expense related to sale of future royalties			4,290	3,278
Royalty distributed to HCR			(2,056)	(353)
Deferred royalty obligation balance as of June 30,	$ 27,761	$ 23,104	$ 27,761	$ 23,104
Healthcare royalty partners IV, L.P | Licensing revenue
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Effective interest rate			33.50%	28.80%